Apolipoprotein B / Apo B (APOB 100) Human Protein

CAT#: BA1030

Apolipoprotein B / Apo B (APOB 100) human protein, 1 mg


USD 330.00

2 Weeks*

Size
    • 1 mg

Product Images

Other products for "APOB"

Specifications

Product Data
Species Human
Protein Source Plasma
Concentration lot specific
Purity Method of Purification:
1. Ultracentrifugation at d 1.03-1.05
2. Delipidation with Diethyl Ether/Ethanol (3/1)
3. Gel filtration over Sephacryl S-200.
Buffer Presentation State: Purified
State: Liquid purified protein
Buffer System: 10mM Tris Buffered Saline, 10mM Sodium Decyl Sulfate, pH 7.4
Preservative: None
Preparation Liquid purified protein
Protein Description Human Apolipoprotein B-100 (Apo B-100).
Devoid of Apo(a), Apo C, and Apo E proteins. Cross-reacts with anti-LDL.
Note Caution: All human source materials have tested negative for HIV 1, HIV 2, HCV antibodies Syphilis, HIV-1 antigen and HBsAg. No test guarantees a product to be non-infectious. Therefore, all material derived from human fluids or tissues should be considered as potentially infectious.
Storage Store undiluted at 2-8°C.
DO NOT FREEZE!
Stability Shelf life: one year from despatch.
Reference Data
RefSeq NP_000375
Locus ID 338
Cytogenetics 2p24.1
Synonyms apoB-48; apoB-100; FCHL2; FLDB; LDLCQ4
Summary 'This gene product is the main apolipoprotein of chylomicrons and low density lipoproteins (LDL), and is the ligand for the LDL receptor. It occurs in plasma as two main isoforms, apoB-48 and apoB-100: the former is synthesized exclusively in the gut and the latter in the liver. The intestinal and the hepatic forms of apoB are encoded by a single gene from a single, very long mRNA. The two isoforms share a common N-terminal sequence. The shorter apoB-48 protein is produced after RNA editing of the apoB-100 transcript at residue 2180 (CAA->UAA), resulting in the creation of a stop codon, and early translation termination. Mutations in this gene or its regulatory region cause hypobetalipoproteinemia, normotriglyceridemic hypobetalipoproteinemia, and hypercholesterolemia due to ligand-defective apoB, diseases affecting plasma cholesterol and apoB levels. [provided by RefSeq, Dec 2019]'
Protein Families Druggable Genome, Transmembrane

Documents

{0} Product Review(s)

0 Product Review(s) Submit review

Be the first one to submit a review

Product Citations

*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.